The FDA is wrapping up its overhaul of monitoring tools for the cosmetics market! The U.S. agency announced on Friday, September 12, 2025, the launch of the FDA Adverse Event Reporting System (FAERS) Public Dashboard for Cosmetic Products, an interactive tool designed to facilitate the public’s ability to query real-time adverse event data on cosmetic products.
This launch follows the FDA’s August 22, 2025, introduction of a tool for tracking adverse events related to drugs and therapeutic biologics. It marks another step in the agency’s broader strategy to modernize its systems and enhance data transparency.
Responsible persons and healthcare professionals
The system offers flexible data access, allowing downloads of all records or specific subsets. Reports are updated daily to include the most recent submissions.
The new platform consolidates adverse event data exclusively for cosmetic products (such as moisturizers, shampoos, conditioners, hair dyes, tattoos), making the data easier to search. It includes serious adverse event reports submitted by responsible persons for cosmetic products under requirements established by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), as well as voluntary adverse event reports submitted to the FDA by healthcare professionals, consumers, salon professionals, cosmetologists and others.
User-friendly queries
The platform users can search and view reports using various search terms including the product name and adverse event term. Additionally, users can filter and sort results by different criteria, such as severity level of the adverse event, date or report type. This comprehensive search capability ensures that users can efficiently locate the specific information they need from the database.
The FDA stresses that it does not verifies the dashboard data. Their inclusion in the platform does not mean the agency has determined that a cosmetic product caused the reported adverse event, nor should the data be viewed as a measure of a product’s overall safety profile.
